Arcadia Biosciences RKDA Balance Sheet (2014-2026)

NASDAQ RKDA
$0.28 -0.03 (-8.86%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Arcadia Biosciences Quarterly Balance Sheet

Periods 49 quarters
Latest Jun 2026

Arcadia Biosciences reported total assets of $5.89M and total liabilities of $5.26M for the quarter ended Jun 2026, down 54.6% year over year. This balance sheet covers 49 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
44.00M35.53M28.68M24.60M21.23M22.72M20.64M23.00M13.50M10.61M6.52M3.32M5.50M3.94M4.24M3.20M1.40M1.12M0.26M4.20M
Short-term InvestmentsInvestments (Current)
5.02M5.10M5.12M5.20M2.60M2.64M3.07M4.76M4.30M
Cash & Current Investments
44.00M35.53M28.68M24.60M21.23M22.72M20.64M23.00M18.52M15.71M11.64M8.52M8.11M6.58M4.24M3.20M4.47M5.88M4.56M4.20M
Receivables - NetNet Receivables
1.15M1.45M1.37M2.77M3.85M2.73M1.20M0.92M0.63M0.30M0.51M0.76M0.84M0.88M1.20M1.61M1.26M0.83M0.42M0.56M
Receivables - OtherOther Receivables
Receivables
1.15M1.45M1.37M2.77M3.85M2.73M1.20M0.92M0.63M0.30M0.51M0.76M0.84M0.88M1.20M1.61M1.26M0.83M0.42M0.56M
Inventory
3.90M5.45M4.43M3.23M3.27M3.34M2.32M2.59M3.16M2.66M0.84M1.83M0.98M0.83M0.90M1.28M1.49M1.46M1.21M0.93M
Prepaid Assets
1.90M1.41M0.90M0.69M1.44M0.99M0.80M0.61M0.95M1.09M0.81M0.54M0.54M0.52M0.93M0.73M0.38M0.21M0.16M0.07M
Current Assets
50.92M43.83M35.39M31.50M30.06M30.03M25.40M27.20M23.34M20.01M14.97M11.64M12.43M10.71M9.24M8.85M7.58M8.39M6.36M5.74M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
3.74M2.63M2.29M1.47M0.95M0.85M0.68M0.62M0.56M0.47M0.07M0.33M0.05M0.06M0.04M0.03M0.01M0.01M0.01M
Long-Term Investments
Goodwill
1.65M1.65M1.65M
Intangibles
4.07M3.90M0.48M0.47M0.39M0.37M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M
Goodwill & Intangibles
5.72M5.55M2.13M0.47M0.39M0.37M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M
Other Non-Current Assets
0.18M0.18M0.18M0.16M0.17M0.17M0.17M0.17M0.18M0.18M3.47M0.16M0.16M0.16M0.09M0.09M0.15M0.15M0.14M0.12M
Non-Current Assets
19.88M15.39M8.53M7.30M4.95M4.44M3.52M3.21M3.46M3.46M4.73M4.40M4.93M4.53M4.28M4.14M0.21M0.20M0.19M0.15M
Assets
70.80M59.23M43.92M38.80M35.01M34.47M28.92M30.41M26.80M23.47M19.70M16.05M17.37M15.24M13.52M12.99M7.79M8.58M6.55M5.89M
Liabilities
Current Liabilities
Accounts Payables
5.19M5.00M3.64M3.44M3.39M2.75M2.85M2.79M2.78M2.60M1.91M1.73M1.56M1.69M2.11M1.90M1.56M2.02M1.79M1.38M
Notes Payables
Payables
5.19M5.00M3.64M3.44M3.39M2.75M2.85M2.79M2.78M2.60M1.91M1.73M1.56M1.69M2.11M1.90M1.56M2.02M1.79M1.38M
Accumulated Expenses
Other Accumulated Expenses
0.26M0.26M0.26M0.26M0.27M0.27M0.30M0.28M0.35M0.37M0.04M0.42M0.41M0.32M0.17M0.33M0.27M0.27M0.26M
Short term Debt
1.14M0.04M
Current Deferred Revenue
0.06M
Total Current Liabilities
7.65M6.49M5.04M4.81M4.74M4.05M4.21M4.10M4.09M3.88M3.59M2.88M2.70M2.33M2.56M2.22M1.84M2.29M2.06M1.65M
Non-Current Liabilities
Non-Current Debt
0.09M0.08M
Convertible Debt
Non-Current Deffered Revenue
Preferred Stock Liabilities
Minority Interest
1.04M0.38M0.10M-0.02M-0.04M-0.05M-0.13M-0.13M-0.14M-0.14M-0.14M-0.14M-0.14M-0.14M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
0.03M
Operating Leases
5.73M2.56M2.22M1.71M1.50M1.27M1.01M0.76M0.53M0.35M0.15M0.02M0.01M
Other Non-Current Liabilities
2.14M2.14M2.07M2.04M2.00M2.00M2.00M2.00M2.00M2.00M2.00M2.00M2.00M2.00M2.00M1.00M
Total Non-Current Liabilities
25.98M16.86M10.65M6.52M6.24M7.46M6.02M11.72M7.07M6.07M5.00M3.56M3.80M3.09M5.29M3.08M3.25M3.14M2.41M
Total Liabilities
28.12M19.00M12.72M8.56M8.24M9.46M8.02M13.72M9.07M8.07M7.00M5.56M5.80M5.09M7.29M4.08M3.25M3.14M2.41M5.26M
Shareholder's Equity
Total Debt
1.23M0.11M
Common Equity
42.68M40.22M31.20M30.24M26.77M25.02M20.90M16.69M17.73M15.40M12.70M10.48M11.57M10.15M6.22M8.90M4.53M5.44M4.14M0.63M
Liabilities and Shareholders Equity
70.80M59.23M43.92M38.80M35.01M34.47M28.92M30.41M26.80M23.47M19.70M16.05M17.37M15.24M13.52M12.99M7.79M8.58M6.55M5.89M
Retained Earnings
-215.03M-217.20M-226.49M-247.00M-250.75M-253.62M-257.86M-267.24M-266.42M-269.00M-271.84M-274.30M-273.20M-274.81M-278.88M-276.30M-280.74M-279.90M-281.22M-291.90M

Arcadia Biosciences Balance Sheet API

Pull Arcadia Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RKDA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY